PL1809602T3 - Pochodne indolowe przydatne jako modulatory receptora progesteronu - Google Patents
Pochodne indolowe przydatne jako modulatory receptora progesteronuInfo
- Publication number
- PL1809602T3 PL1809602T3 PL05816083T PL05816083T PL1809602T3 PL 1809602 T3 PL1809602 T3 PL 1809602T3 PL 05816083 T PL05816083 T PL 05816083T PL 05816083 T PL05816083 T PL 05816083T PL 1809602 T3 PL1809602 T3 PL 1809602T3
- Authority
- PL
- Poland
- Prior art keywords
- progesterone receptor
- indole derivatives
- receptor modulators
- derivatives useful
- prevention
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62258204P | 2004-10-27 | 2004-10-27 | |
| PCT/US2005/037817 WO2006049889A1 (en) | 2004-10-27 | 2005-10-21 | Indole derivatives useful as progesterone receptor modulators |
| EP05816083A EP1809602B1 (en) | 2004-10-27 | 2005-10-21 | Indole derivatives useful as progesterone receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1809602T3 true PL1809602T3 (pl) | 2009-04-30 |
Family
ID=35735187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05816083T PL1809602T3 (pl) | 2004-10-27 | 2005-10-21 | Pochodne indolowe przydatne jako modulatory receptora progesteronu |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7183309B2 (pl) |
| EP (1) | EP1809602B1 (pl) |
| JP (1) | JP5190268B2 (pl) |
| CN (1) | CN101087758B (pl) |
| AT (1) | ATE412631T1 (pl) |
| AU (1) | AU2005302706B2 (pl) |
| CA (1) | CA2585334C (pl) |
| CY (1) | CY1109919T1 (pl) |
| DE (1) | DE602005010734D1 (pl) |
| DK (1) | DK1809602T3 (pl) |
| ES (1) | ES2314739T3 (pl) |
| PL (1) | PL1809602T3 (pl) |
| PT (1) | PT1809602E (pl) |
| SI (1) | SI1809602T1 (pl) |
| WO (1) | WO2006049889A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ568910A (en) | 2006-01-24 | 2011-04-29 | Lilly Co Eli | Indole sulfonamide modulators of progesterone receptors |
| CA2684450C (en) * | 2007-04-20 | 2017-05-30 | Preglem S.A. | Progesterone antagonist and selective progesterone modulator in the treatment of excessive uterine bleeding |
| CN111153849B (zh) * | 2019-12-19 | 2021-03-26 | 南京林业大学 | 一种2-吲哚甲醇在水相反应体系中合成c3位硫醚化吲哚衍生物的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5081138A (en) * | 1986-12-17 | 1992-01-14 | Merck Frosst Canada, Inc. | 3-hetero-substituted-n-benzyl-indoles and prevention of leucotriene synthesis therewith |
| US5851247A (en) * | 1997-02-24 | 1998-12-22 | Minnesota Mining & Manufacturing Company | Structured abrasive article adapted to abrade a mild steel workpiece |
| UA68365C2 (en) * | 1997-11-06 | 2004-08-16 | Wyeth Corp | Peroral contraception by combination of anti-estrogen and progestin |
| IL137540A0 (en) | 1998-02-25 | 2001-07-24 | Genetics Inst | Inhibitors of phospholipase a2 |
| US6355648B1 (en) | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
| BR0208790A (pt) * | 2001-04-11 | 2004-03-30 | Idenix Cayman Ltd | Fenilindoìs para o tratamento de hiv |
| SE0201635D0 (sv) * | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
| SE0202241D0 (sv) * | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
-
2005
- 2005-10-21 CN CN2005800446115A patent/CN101087758B/zh not_active Expired - Fee Related
- 2005-10-21 US US11/255,444 patent/US7183309B2/en not_active Expired - Fee Related
- 2005-10-21 WO PCT/US2005/037817 patent/WO2006049889A1/en active Application Filing
- 2005-10-21 ES ES05816083T patent/ES2314739T3/es active Active
- 2005-10-21 AT AT05816083T patent/ATE412631T1/de active
- 2005-10-21 DK DK05816083T patent/DK1809602T3/da active
- 2005-10-21 CA CA2585334A patent/CA2585334C/en not_active Expired - Fee Related
- 2005-10-21 PL PL05816083T patent/PL1809602T3/pl unknown
- 2005-10-21 AU AU2005302706A patent/AU2005302706B2/en not_active Ceased
- 2005-10-21 PT PT05816083T patent/PT1809602E/pt unknown
- 2005-10-21 DE DE602005010734T patent/DE602005010734D1/de active Active
- 2005-10-21 JP JP2007538996A patent/JP5190268B2/ja not_active Expired - Fee Related
- 2005-10-21 EP EP05816083A patent/EP1809602B1/en not_active Not-in-force
- 2005-10-21 SI SI200530551T patent/SI1809602T1/sl unknown
-
2007
- 2007-01-16 US US11/623,376 patent/US7345084B2/en not_active Expired - Fee Related
-
2009
- 2009-01-27 CY CY20091100097T patent/CY1109919T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20070135511A1 (en) | 2007-06-14 |
| SI1809602T1 (sl) | 2009-04-30 |
| DK1809602T3 (da) | 2009-02-16 |
| US20060111427A1 (en) | 2006-05-25 |
| WO2006049889A1 (en) | 2006-05-11 |
| ES2314739T3 (es) | 2009-03-16 |
| EP1809602A1 (en) | 2007-07-25 |
| US7345084B2 (en) | 2008-03-18 |
| CN101087758A (zh) | 2007-12-12 |
| CY1109919T1 (el) | 2014-09-10 |
| US7183309B2 (en) | 2007-02-27 |
| PT1809602E (pt) | 2008-12-15 |
| AU2005302706B2 (en) | 2011-12-15 |
| CN101087758B (zh) | 2012-06-06 |
| JP2008518009A (ja) | 2008-05-29 |
| EP1809602B1 (en) | 2008-10-29 |
| CA2585334A1 (en) | 2006-05-11 |
| DE602005010734D1 (de) | 2008-12-11 |
| JP5190268B2 (ja) | 2013-04-24 |
| CA2585334C (en) | 2014-05-13 |
| ATE412631T1 (de) | 2008-11-15 |
| AU2005302706A1 (en) | 2006-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005019905D1 (de) | -modulatoren | |
| ECSP18047708A (es) | Derivados de 17-hidroxi-17-pentafluoroetil-estra-4,9(10)-dien-11-arilo como antagonistas de progesterona y procedimientos para su preparación | |
| EP1896034B8 (en) | Micronized tanaproget compositions and methods of preparing the same | |
| EA201200860A1 (ru) | Нейтрализующие пролактиновый рецептор антитела и их терапевтическое применение | |
| TW200716621A (en) | Polymorph form II of tanaproget | |
| WO2000066165A8 (en) | Contraceptive compositions containing quinazolinone and benzoxazine derivatives | |
| EP1877059B8 (en) | Micronized tanaproget and compostions containing same | |
| BR0316843A (pt) | Derivados tetracìclicos contendo heteroátomo como moduladores seletivos do receptor de estrogênio | |
| WO2011098437A3 (de) | Progesteronrezeptorantagonisten | |
| ATE434434T1 (de) | Zusammensetzungen mit mikronisiertem tanaproget | |
| TR200103285T2 (tr) | Projesteron reseptörü modülatörleri olarak siklokarbamat türevleri. | |
| PL1809602T3 (pl) | Pochodne indolowe przydatne jako modulatory receptora progesteronu | |
| EA200702604A1 (ru) | Производные бензофуранона как нестероидные модуляторы рецептора прогестерона | |
| ATE275973T1 (de) | Empfängnisverhütende zusammensetzungen die progestagen und progesteronantagonisten enthalten | |
| EA200702524A1 (ru) | Нестероидные модуляторы рецептора прогестерона | |
| MA32477B1 (fr) | Derives estratrienes comprenant des bioisosteres heterocycliques pour le cycle a phenolique | |
| EA201501011A1 (ru) | Дозированная форма антагониста рецептора прогестерона | |
| WO2008109055A3 (en) | Cyanopyrrole sulfonamides useful for modulation of the progesterone receptor | |
| AR023854A1 (es) | Uso de derivados de indolina y equipo farmaceutico para regimenes ciclicos |